34 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Why Cigna (CI) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2246671/why-cigna-ci-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2246671 Mar 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar https://www.zacks.com/stock/news/2245868/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245868 Mar 26, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
UnitedHealth (UNH) to Roll Out Medical Claims Software Soon https://www.zacks.com/stock/news/2243009/unitedhealth-unh-to-roll-out-medical-claims-software-soon?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243009 Mar 19, 2024 - UnitedHealth (UNH) assists care providers with more than $2 billion through several initiatives to mitigate the cash flow crunch arising from the cyberattack.
Here's Why You Should Retain Centene (CNC) Stock for Now https://www.zacks.com/stock/news/2242211/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242211 Mar 18, 2024 - Robust growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
Are These 3 Beaten-Down S&P 500 Members Worth a Look? https://www.zacks.com/commentary/2241645/are-these-3-beaten-down-s-p-500-members-worth-a-look?cid=CS-ZC-FT-investment_ideas-2241645 Mar 15, 2024 - The market has enjoyed a fantastic run in 2024, building nicely on last year???s gains. But not all have joined the party, specifically these three. Deep in the red year-to-date, are they worth a look?
Why Elevance (ELV) is a Smart Addition to Your Portfolio Now https://www.zacks.com/stock/news/2241626/why-elevance-elv-is-a-smart-addition-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2241626 Mar 15, 2024 - Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues.
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics https://www.zacks.com/stock/news/2238726/the-joint-jynt-rises-30-as-q4-earnings-beat-on-higher-clinics?cid=CS-ZC-FT-analyst_blog|earnings_article-2238726 Mar 11, 2024 - The Joint (JYNT) expects 2024 system-wide sales to be within $530-$545 million.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2238612/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2238612 Mar 11, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Top-Ranked Stocks to Buy for Stability https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265 Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
HCA Healthcare (HCA) Rises 24.8% in a Year: More Room to Run? https://www.zacks.com/stock/news/2236168/hca-healthcare-hca-rises-24-8-in-a-year-more-room-to-run?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2236168 Mar 05, 2024 - HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.

Pages: 1234

Page 1>